Dear Research Advocate, Phase 3 enrollment is now underway for a number of COVID-19 vaccine clinical trials. That science has moved so quickly from first identification of the virus to Phase 3 trials, speaks to remarkable public-private sector collaboration. It also speaks to the absolute necessity of taxpayer investment in basic, discovery science over many years; a lesson we must not ignore as we plan responses to the pandemics that will surely follow. To help move the massive trial enrollment process along, NIH has launched the COVID-19 Prevention Trials Network (COVPN), merging networks already funded by NIAID for HIV and other infectious disease trials. Each of the Phase 3 clinical...

Sidebar Quote

Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor